Event Date/Time: Feb 27, 2012
End Date/Time: Feb 28, 2012
To address the continuing advances in disease therapies, as well as solving unmet needs of ocular disease drug therapies in aging individuals, GTCbio is proud to announce its 4th Ocular Diseases & Drug Discovery Conference, taking place on February 27-28, 2012 in Las Vegas, Nevada. Several companies have taken the initiative in developing ocular disease therapies, with exciting new developments in kinase inhibitors. These companies include Pfizer, EyeGate, pSivida, Merck, Regeneron, Genzyme, Novartis, Ophthotech, Macusight, Neurotech, GlaxoSmithKline and many more.
To help promote the discovery of ocular disease and drug development, GTCbio is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research and drugs available in combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases at the 4th Ocular Diseases & Drug Discovery Conference.